vecuronium bromide has been researched along with Diabetes Mellitus, Type 2 in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (75.00) | 29.6817 |
| 2010's | 1 (25.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Saitoh, Y | 1 |
| Abe, S; Haraga, I; Higa, K; Nitahara, K; Shigematsu, K; Sugi, Y | 1 |
| Hattori, H; Kaneda, K; Murakawa, M; Nakajima, H; Saitoh, Y | 1 |
| Akatu, M; Hattori, H; Murakawa, M; Nakajima, H; Saitoh, Y; Sanbe, N | 1 |
1 trial(s) available for vecuronium bromide and Diabetes Mellitus, Type 2
| Article | Year |
|---|---|
Monitoring of neuromuscular block after administration of vecuronium in patients with diabetes mellitus.
Topics: Adult; Aged; Anesthesia, Inhalation; Diabetes Mellitus, Type 2; Electric Stimulation; Electromyography; Female; Humans; Male; Middle Aged; Monitoring, Intraoperative; Neuromuscular Blockade; Neuromuscular Junction; Neuromuscular Nondepolarizing Agents; Vecuronium Bromide | 2003 |
3 other study(ies) available for vecuronium bromide and Diabetes Mellitus, Type 2
| Article | Year |
|---|---|
[Monitoring of neuromuscular block in patients with diabetes mellitus, hypercholesterolemia, and hypertriglyceridemia].
Topics: Adult; Diabetes Mellitus, Type 2; Humans; Hypercholesterolemia; Hypertriglyceridemia; Monitoring, Physiologic; Muscle Relaxation; Neuromuscular Blockade; Vecuronium Bromide | 2009 |
Recovery of train-of-four ratio to 0.70 and 0.90 is delayed in type 2 diabetes with vecuronium-induced neuromuscular block.
Topics: Adult; Aged; Anesthesia Recovery Period; Case-Control Studies; Diabetes Mellitus, Type 2; Electromyography; Female; Humans; Male; Middle Aged; Neuromuscular Blockade; Neuromuscular Monitoring; Neuromuscular Nondepolarizing Agents; Prospective Studies; Vecuronium Bromide; Young Adult | 2013 |
Reversal of vecuronium with neostigmine in patients with diabetes mellitus.
Topics: Aged; Cholinesterase Inhibitors; Diabetes Mellitus, Type 2; Female; Humans; Male; Middle Aged; Neostigmine; Neuromuscular Blockade; Neuromuscular Nondepolarizing Agents; Respiration; Vecuronium Bromide | 2004 |